Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
No immunity after series; This non-serious case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a patient who received Herpes zoster (Shingrix) for prophylaxis. The patient received Shingrix. After receiving Shingrix, the patient experienced therapy non-responder (Verbatim: No immunity after series). The outcome of the therapy non-responder was not applicable.